{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:15:01Z","timestamp":1786990501410,"version":"build-2736575974"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2023AFB966"],"award-info":[{"award-number":["2023AFB966"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204320"],"award-info":[{"award-number":["82204320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijbiomac.2024.138533","type":"journal-article","created":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T12:03:25Z","timestamp":1733659405000},"page":"138533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Novel drug delivery systems for hirudin-based product development and clinical applications"],"prefix":"10.1016","volume":"287","author":[{"given":"Liqing","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuecheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/biof.1913","article-title":"Translational aspect in peptide drug discovery and development: an emerging therapeutic candidate","volume":"49","author":"Anand","year":"2023","journal-title":"Biofactors"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.138533_bb0015","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.2174\/0929866525666181114155542","article-title":"Building on success: a bright future for peptide therapeutics","volume":"25","author":"Angell","year":"2019","journal-title":"Protein Pept. Lett."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138533_bb0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00114-012-0906-4","article-title":"The Hirudo medicinalis species complex","volume":"99","author":"Kutschera","year":"2012","journal-title":"Naturwissenschaften"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.138533_bb0025","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.imr.2017.08.001","article-title":"Medicinal leech therapy-an overall perspective","volume":"6","author":"Sig","year":"2017","journal-title":"Integr. Med. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01061990","article-title":"Hirudin: its biology and clinical use","volume":"1","author":"Becker","year":"1994","journal-title":"J. Thromb. Thrombolysis"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.138533_bb0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1054-8807(96)00045-2","article-title":"Pharmacology and controlled release of hirudin for cardiovascular disorders","volume":"5","author":"Kim","year":"1996","journal-title":"Cardiovasc. Pathol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1432-1033.1991.tb16345.x","article-title":"Characterization, stability and refolding of recombinant hirudin","volume":"202","author":"Otto","year":"1991","journal-title":"Eur. J. Biochem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138533_bb0045","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0049-3848(88)90023-0","article-title":"Clinico-pharmacological studies with recombinant hirudin","volume":"52","author":"Markwardt","year":"1988","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.660757","article-title":"Pharmacological activities and mechanisms of hirudin and its derivatives - a review","volume":"12","author":"Junren","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112878","article-title":"From ancient leech to direct thrombin inhibitors and beyond: New from old","volume":"149","author":"Montinari","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002512-199608030-00003","article-title":"Pharmacological properties of hirudin and its derivatives. Potential clinical advantages over heparin","volume":"8","author":"Monreal","year":"1996","journal-title":"Drugs Aging"},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.138533_bb0065","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1111\/bph.15816","article-title":"Molecular dynamic and pharmacological studies on protein-engineered hirudin variants of Hirudinaria manillensis and Hirudo medicinalis","volume":"179","author":"Sun","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138533_bb0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-2002-35292","article-title":"Hirudin as alternative anticoagulant--a historical review","volume":"28","author":"Markwardt","year":"2002","journal-title":"Semin. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0075","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0014-5793(84)80165-9","article-title":"The complete amino acid sequence of hirudin, a thrombin specific inhibitor: application of colour carboxymethylation","volume":"165","author":"Dodt","year":"1984","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.138533_bb0080","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1515\/bchm3.1985.366.1.379","article-title":"The complete covalent structure of hirudin. Localization of the disulfide bonds","volume":"366","author":"Dodt","year":"1985","journal-title":"Biol. Chem. Hoppe Seyler"},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2024.138533_bb0085","first-page":"27","article-title":"Thrombin inhibition by hirudin: how hirudin inhibits thrombin","volume":"21","author":"Fenton","year":"1991","journal-title":"Haemostasis"},{"issue":"07","key":"10.1016\/j.ijbiomac.2024.138533_bb0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1160\/TH07-05-0364","article-title":"Hirudin \u2013 the long and stony way from an anticoagulant peptide in the saliva of medicinal leech to a recombinant drug and beyond","volume":"98","author":"Nowak","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-2007-1002600","article-title":"Toxicology of hirudin","volume":"17","author":"Kl\u00f6cking","year":"1991","journal-title":"Semin. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-2007-1002603","article-title":"Pharmacokinetics of hirudin","volume":"17","author":"Nowak","year":"1991","journal-title":"Semin. Thromb. Hemost."},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.138533_bb0105","first-page":"5806","article-title":"Research progress on processing history evolution, chemical constituents, and pharmacological effects of Hirudo","volume":"47","author":"Jiang","year":"2022","journal-title":"China J. Chin. Mater. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0049-3848(73)90086-8","article-title":"Large scale preparation of hirudin","volume":"2","author":"Bagdy","year":"1973","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00001721-199102000-00013","article-title":"Isolation of thrombin inhibitor from the leech Hirudinaria manillensis","volume":"2","author":"Electricwala","year":"1991","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0120","series-title":"Isolation and Purification of Hirudin From Hirudinaria Manillensis in Guang Xi, China","first-page":"523","author":"L.C.-g.Z.-F.T.Y.L.A.-Z.L.Y.-C. He","year":"2004"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0125","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-2007-1002721","article-title":"Production and evaluation of recombinant hirudin","volume":"15","author":"Courtney","year":"1989","journal-title":"Semin. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1055\/s-2007-1002594","article-title":"Recombinant hirudin: genetic engineering and structure analysis","volume":"17","author":"M\u00e4rki","year":"1991","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0135","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2147\/DDDT.S353088","article-title":"The antithrombotic effect of recombinant neorudin on thrombi","volume":"16","author":"Liu","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1586\/14779072.2.3.339","article-title":"Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy","volume":"2","author":"Greinacher","year":"2004","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.138533_bb0145","first-page":"830","article-title":"Bivalirudin","volume":"99","author":"Koster","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0150","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood.V114.22.3131.3131","article-title":"Lack of clinically significant interactions between the subcutaneously administered direct thrombin inhibitor desirudin and orally administered warfarin upon the international normalized ratio","volume":"114","author":"Levy","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.138533_bb0155","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1586\/erc.11.131","article-title":"Desirudin: a review of the pharmacology and clinical application for the prevention of deep vein thrombosis","volume":"9","author":"Graetz","year":"2011","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0160","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jchromb.2017.08.030","volume":"1063","author":"Dong","year":"2017","journal-title":"J. Chromatogr. B"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.138533_bb0165","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s10930-012-9407-8","article-title":"Construction, expression and refolding of a bifunctional fusion protein consisting of C-Terminal 12-Residue of Hirudin-PA and reteplase","volume":"31","author":"Gao","year":"2012","journal-title":"Protein J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12896-018-0431-4","article-title":"A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss","volume":"18","author":"Sheffield","year":"2018","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.crgsc.2023.100358","article-title":"A review of coagulation explaining its definition, mechanism, coagulant types, and optimization models; RSM, and ANN","author":"El-Taweel","year":"2023","journal-title":"Curr. Res. Green Sustain. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138533_bb0180","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1213\/ane.0b013e31819bcc9c","article-title":"Blood coagulation: hemostasis and thrombin regulation","volume":"108","author":"Tanaka","year":"2009","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0185","first-page":"59","article-title":"Thrombin in the crossroad hemostasis and inflammation","volume":"5","author":"Starikova","year":"2023","journal-title":"J. Evol. Biochem. Physiol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0190","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/s-2007-1002719","article-title":"Development of hirudin as an antithrombotic agent","volume":"15","author":"Markwardt","year":"1989","journal-title":"Semin. Thromb. Hemost."},{"issue":"20","key":"10.1016\/j.ijbiomac.2024.138533_bb0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/cells11203214","article-title":"Anticoagulants: a short history, their mechanism of action, pharmacology, and indications","volume":"11","author":"Heestermans","year":"2022","journal-title":"Cells"},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2024.138533_bb0200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1027385304093","article-title":"Hirudin-based anticoagulant strategies for patients with suspected heparin-induced thrombocytopenia undergoing percutaneous coronary interventions and bypass grafting","volume":"10","author":"Becker","year":"2000","journal-title":"J. Thromb. Thrombolysis"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.138533_bb0205","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/039139880502801211","article-title":"Effect of hirudin versus heparin on hemocompatibility of blood contacting biomaterials: an in vitro study","volume":"28","author":"Kopp","year":"2005","journal-title":"Int. J. Artif. Organs"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138533_bb0210","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.7150\/ijms.52752","article-title":"The efficacy and safety of hirudin plus aspirin versus warfarin in the secondary prevention of cardioembolic stroke due to nonvalvular atrial fibrillation: a multicenter prospective cohort study","volume":"18","author":"Song","year":"2021","journal-title":"Int. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0215","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0021-9258(17)35224-9","article-title":"Hirudin: amino-terminal residues play a major role in the interaction with thrombin","volume":"266","author":"Lazar","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0220","first-page":"93","article-title":"Fibrosis--a common pathway to organ injury and failure","volume":"373","author":"Urban ML","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0225","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases","volume":"117","author":"Wynn","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0230","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.arr.2017.11.002","article-title":"FOXO1\/3: potential suppressors of fibrosis","volume":"41","author":"Xin","year":"2018","journal-title":"Ageing Res. Rev."},{"issue":"7835","key":"10.1016\/j.ijbiomac.2024.138533_bb0235","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.138533_bb0240","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/j.2040-4603.2016.tb00731.x","article-title":"Adipose tissue-derived plasminogen activator inhibitor-1 function and regulation","volume":"6","author":"Kaji","year":"2016","journal-title":"Comprehen. Physiol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138533_bb0245","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1248\/bpb.b16-00832","article-title":"Hydrogen rich water attenuates renal injury and fibrosis by regulation transforming growth factor-\u03b2 induced Sirt1","volume":"40","author":"Xing","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0250","doi-asserted-by":"crossref","first-page":"7291075","DOI":"10.1155\/2020\/7291075","article-title":"Hirudin ameliorates renal interstitial fibrosis via regulating TGF-\u03b21\/Smad and NF-\u03baB signaling in UUO rat model","volume":"2020","author":"Yang","year":"2020","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0255","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00441-016-2464-0","article-title":"Epithelial-mesenchymal transition in tissue repair and fibrosis","volume":"365","author":"Stone","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0260","article-title":"A molecular mechanism study to reveal hirudin's downregulation to PI3K\/AKT signaling pathway through decreasing PDGFR\u03b2 in renal fibrosis treatment","volume":"2022","author":"Li","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146269","article-title":"The role of exosomal CDC6 in the hirudin-mediated suppression of the malignant phenotype of bladder cancer cells","volume":"821","author":"Shen","year":"2022","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0270","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/157489209787002461","article-title":"Recent developments in anti-cancer agents targeting the Ras\/Raf\/ MEK\/ERK pathway","volume":"4","author":"Wong","year":"2009","journal-title":"Recent Patents Anti-canc. Drug Discov."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.138533_bb0275","first-page":"20983","article-title":"Hirudin inhibits cell growth via ERK\/MAPK signaling in human glioma","volume":"8","author":"Zhao","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0280","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3892\/or.2015.3717","article-title":"Recombinant hirudin suppresses the viability, adhesion, migration and invasion of Hep-2 human laryngeal cancer cells","volume":"33","author":"Lu","year":"2015","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.138533_bb0285","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.138533_bb0290","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0295","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tice.2015.04.001","article-title":"Hirudin promotes angiogenesis by modulating the cross-talk between p38 MAPK and ERK in rat ischemic skin flap tissue","volume":"47","author":"Pan","year":"2015","journal-title":"Tissue Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0300","doi-asserted-by":"crossref","first-page":"82","DOI":"10.9738\/CC171.1","article-title":"Effects of natural and recombinant hirudin on VEGF expression and random skin flap survival in a venous congested rat model","volume":"98","author":"Yingxin","year":"2013","journal-title":"Int. Surg."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0305","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/597264","article-title":"Natural hirudin increases rat flap viability by anti-inflammation via PARs\/p38\/NF-\u03baB pathway","volume":"2015","author":"Peng","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.138533_bb0310","first-page":"1674","article-title":"Hyperuricemia and progression of chronic kidney disease: a review from physiology and pathogenesis to the role of urate-lowering therapy","volume":"11","author":"Lee","year":"2021","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"36","key":"10.1016\/j.ijbiomac.2024.138533_bb0315","doi-asserted-by":"crossref","first-page":"15501","DOI":"10.1073\/pnas.0904411106","article-title":"Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy","volume":"106","author":"Preitner","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5049\/EBP.2021.19.1.1","article-title":"Urate transporters in the kidney: what clinicians need to know","volume":"19","author":"Chung","year":"2021","journal-title":"Electrolyte Blood Press."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.138533_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaim.2024.100949","article-title":"Exploration of leech therapy in treating gouty rats and its uric acid lowering mechanism","volume":"15","author":"Chao","year":"2024","journal-title":"J. Ayurveda Integ. Med."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0330","article-title":"Hirudin regulates vascular function in chronic renal failure through modulating macrophage polarization","volume":"2022","author":"Chen","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0335","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.921894","article-title":"Hirudin reduces the expression of markers of the extracellular matrix in renal tubular epithelial cells in a rat model of diabetic kidney disease through the hypoxia-inducible Factor-1\u03b1 (HIF-1\u03b1)\/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway","volume":"26","author":"Pang","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0340","series-title":"Atherosclerosis: The Involvement of Immunity, Cytokines and Cells in Pathogenesis, and Potential Novel Therapeutics, Aging and Disease","first-page":"1214","volume":"14(4)","author":"Su","year":"2023"},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0345","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2121-14-32","article-title":"Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis","volume":"14","author":"Brentnall","year":"2013","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0350","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2018.07.014","article-title":"Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions","volume":"276","author":"Raggi","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104414","article-title":"Disocin prevents postmenopausal atherosclerosis in ovariectomized LDLR\u2212\/\u2212 mice through a PGC-1\u03b1\/ER\u03b1 pathway leading to promotion of autophagy and inhibition of oxidative stress, inflammation and apoptosis","volume":"148","author":"Yang","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0360","series-title":"Recombinant Hirudin Protects the Vasculature and Myocardium in Atherosclerotic Rats by Inhibiting the p38 MAPK\/NF-\u03baB Signaling Pathway","author":"Guo","year":"2021"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0365","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pop.2015.05.012","article-title":"Cataracts","volume":"42","author":"Thompson","year":"2015","journal-title":"Prim. Care"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0370","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/bjophthalmol-2021-319834","article-title":"New insights into change of lens proteins' stability with ageing under physiological conditions","volume":"107","author":"Luo","year":"2023","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0375","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/630651","article-title":"Inhibitory effect of r-hirudin variant III on streptozotocin-induced diabetic cataracts in rats","volume":"2013","author":"Gong","year":"2013","journal-title":"ScientificWorldJournal"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0380","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cbi.2008.02.012","article-title":"Potential use of hirudin in diabetic cataract: a study of galactose mediated human lens epithelial cells injury","volume":"173","author":"Ou","year":"2008","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0385","article-title":"IgA nephropathy: current understanding and perspectives on pathogenesis and targeted treatment","volume":"13","author":"Du","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0390","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/0886022X.2019.1583113","article-title":"Hirudin ameliorates immunoglobulin A nephropathy by inhibition of fibrosis and inflammatory response","volume":"41","author":"Deng","year":"2019","journal-title":"Ren. Fail."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108967","article-title":"Hirudin alleviates acute ischemic stroke by inhibiting NLRP3 inflammasome-mediated neuroinflammation: in vivo and in vitro approaches","volume":"110","author":"Li","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106436","article-title":"Cryptochlorogenic acid attenuates LPS-induced inflammatory response and oxidative stress via upregulation of the Nrf2\/HO-1 signaling pathway in RAW 264.7 macrophages","volume":"83","author":"Zhao","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0405","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00281-022-00914-y","article-title":"Atherosclerosis and multi-organ-associated pathologies","volume":"44","author":"Keeter","year":"2022","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0410","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00395-021-00863-x","article-title":"Cytokines as therapeutic targets for cardio- and cerebrovascular diseases","volume":"116","author":"Liberale","year":"2021","journal-title":"Basic Res. Cardiol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0415","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2459\/JCM.0000000000000740","article-title":"Impact of preclinical carotid atherosclerosis on global cardiovascular risk stratification and events in a 10-year follow-up: comparison between the algorithms of the Framingham Heart Study, the European SCORE and the Italian 'Progetto Cuore'","volume":"20","author":"Novo","year":"2019","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.138533_bb0420","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.16341","article-title":"Trends and Risk Factors Associated With Stroke Recurrence in China, 2007\u20132018","volume":"5","author":"Xu","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0425","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/467936","article-title":"Novel drugs development for cardio\u2212\/cerebrovascular diseases","volume":"2014","author":"Sheu","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105737","article-title":"Differences in the prevention and control of cardiovascular and cerebrovascular diseases","volume":"170","author":"Liu","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.138533_bb0435","doi-asserted-by":"crossref","first-page":"12772","DOI":"10.3390\/ijms232112772","article-title":"Platelets and their role in hemostasis and thrombosis-from physiology to pathophysiology and therapeutic implications","volume":"23","author":"Scridon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.138533_bb0440","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.3390\/ijms21217906","article-title":"Molecular drivers of platelet activation: unraveling novel targets for anti-thrombotic and anti-thrombo-inflammatory therapy","volume":"21","author":"Chatterjee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.138533_bb0445","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population-based study","volume":"5","author":"Naess","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0450","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-996082","article-title":"Recombinant hirudin in the prevention of venous thromboembolism in patients undergoing elective hip surgery","volume":"23","author":"Agnelli","year":"1997","journal-title":"Semin. Thromb. Hemost."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138533_bb0455","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1046\/j.1538-7836.2003.00201.x","article-title":"Acute antithrombotic effects of ximelagatran, an oral direct thrombin inhibitor, and r-hirudin in a human ex vivo model of arterial thrombosis","volume":"1","author":"Sarich","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.138533_bb0460","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1161\/STROKEAHA.108.518415","article-title":"Proposal for a universal definition of cerebral infarction","volume":"39","author":"Saver","year":"2008","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.138533_bb0465","first-page":"496","article-title":"Pharmacodynamic advantages and characteristics of traditional Chinese medicine in prevention and treatment of ischemic stroke","volume":"15","author":"Zhang","year":"2023","journal-title":"Chin. Herb. Med."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.138533_bb0470","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s10072-017-2938-1","article-title":"Pathogenic mechanisms following ischemic stroke","volume":"38","author":"Khoshnam","year":"2017","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0475","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.5070","article-title":"Neuronal injuries in cerebral infarction and ischemic stroke: from mechanisms to treatment (review)","volume":"49","author":"Zhao","year":"2022","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138533_bb0480","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/neup.12897","article-title":"Intracerebral hirudin injection alleviates cognitive impairment and oxidative stress and promotes hippocampal neurogenesis in rats subjected to cerebral ischemia","volume":"43","author":"Xia","year":"2023","journal-title":"Neuropathology"},{"issue":"9675","key":"10.1016\/j.ijbiomac.2024.138533_bb0485","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0140-6736(09)60371-8","article-title":"Intracerebral haemorrhage","volume":"373","author":"Qureshi","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0490","article-title":"Ultrasmall iron-gallic acid coordination polymer nanodots with antioxidative neuroprotection for PET\/MR imaging-guided ischemia stroke therapy","volume":"3","author":"Du","year":"2023","journal-title":"Exploration (Beijing, China)"},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0495","article-title":"Treatment of intracerebral hemorrhage - an overview","volume":"120","author":"Mazya","year":"2023","journal-title":"Lakartidningen"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0500","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.4238\/2014.June.18.4","article-title":"Effects of thrombin on the secondary cerebral injury of perihematomal tissues of rats after intracerebral hemorrhage","volume":"13","author":"Liu","year":"2014","journal-title":"Genet. Mol. Res."},{"issue":"19","key":"10.1016\/j.ijbiomac.2024.138533_bb0505","first-page":"71","article-title":"Effect of Maixuekang enteric coated tablets on absorption of hematoma and treatment of acute cerebral hemorrhage patients with cerebral edema","volume":"22","author":"Lu","year":"2016","journal-title":"J. Hainan Med. Univ."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2012.07.064","article-title":"Pathogenesis of acute coronary syndromes","volume":"61","author":"Crea","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.138533_bb0515","article-title":"Pathophysiology of acute coronary syndromes-diagnostic and treatment considerations","volume":"13","author":"Theofilis","year":"2023","journal-title":"Life (Basel)"},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.138533_bb0520","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.138533_bb0525","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00019501-199606000-00005","article-title":"Clinical trials of recombinant hirudin in acute coronary syndromes","volume":"7","author":"Challapalli","year":"1996","journal-title":"Coron. Artery Dis."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.138533_bb0530","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0735-1097(95)00371-1","article-title":"Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina","volume":"26","author":"Rupprecht","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.138533_bb0535","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/15563650.2014.917181","article-title":"Heparin-induced thrombocytopenia","volume":"52","author":"Lovecchio","year":"2014","journal-title":"Clin. Toxicol. (Phila)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0540","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/NAN.0000000000000215","article-title":"Heparin-Induced Thrombocytopenia","volume":"40","author":"Frazer","year":"2017","journal-title":"J. Infus. Nurs."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0545","article-title":"Recombinant hirudin in the treatment of heparin induced thrombocytopenia (HIT) type II","volume":"31","author":"Janssons","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.138533_bb0550","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1182\/blood-2004-02-0621","article-title":"Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies","volume":"104","author":"Lubenow","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138533_bb0555","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","article-title":"Targeting the progression of chronic kidney disease","volume":"16","author":"Ruiz-Ortega","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138533_bb0560","article-title":"Chronic kidney disease as a systemic inflammatory syndrome: update on mechanisms involved and potential treatment","volume":"11","author":"Tinti","year":"2021","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010408","article-title":"Fibrosis in chronic kidney disease: pathogenesis and consequences","volume":"22","author":"Panizo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.138533_bb0570","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nri3523","article-title":"The immune system and kidney disease: basic concepts and clinical implications","volume":"13","author":"Kurts","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0575","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1046\/j.1523-1755.56.s72.2.x","article-title":"Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis","volume":"Suppl (72)","author":"Fischer","year":"1999","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0580","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3736\/jcim20080306","article-title":"Efficacy of hirudin in treating immunoglobulin A nephropathy with hematuria: a randomized controlled trial","volume":"6","author":"Li","year":"2008","journal-title":"J. Chin. Integ. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.138533_bb0585","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1046\/j.1523-1755.2000.00431.x","article-title":"Pharmacodynamics and pharmacokinetics of polyethylene glycol-hirudin in patients with chronic renal failure","volume":"58","author":"P\u00f6schel","year":"2000","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.138533_bb0590","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.apsb.2021.04.001","article-title":"Oral delivery of proteins and peptides: Challenges, status quo and future perspectives","volume":"11","author":"Zhu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0595","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020484","article-title":"Advances in oral drug delivery systems: challenges and opportunities","volume":"15","author":"Lou","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0600","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.mattod.2023.01.002","article-title":"Oral drug delivery platforms for biomedical applications","volume":"62","author":"Ouyang","year":"2023","journal-title":"Mater. Today"},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.618411","article-title":"Advances in oral drug delivery","volume":"12","author":"Alqahtani","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.138533_bb0610","doi-asserted-by":"crossref","DOI":"10.3390\/ph15080975","article-title":"Intestinal absorption study: challenges and absorption enhancement strategies in improving oral drug delivery","volume":"15","author":"Azman","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0615","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.crfs.2022.10.031","article-title":"Advances in the stability challenges of bioactive peptides and improvement strategies","volume":"5","author":"Pei","year":"2022","journal-title":"Curr. Res. Food Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0620","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.7150\/thno.61747","article-title":"Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.138533_bb0625","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/(SICI)1097-4628(19981212)70:11<2143::AID-APP7>3.0.CO;2-L","article-title":"Chitosan\/polyethylene glycol\u2013alginate microcapsules for oral delivery of hirudin","volume":"70","author":"Chandy","year":"1998","journal-title":"J. Appl. Polym. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0630","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd1304","article-title":"Current status and future potential of transdermal drug delivery","volume":"3","author":"Prausnitz","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0635","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2022.09.025","article-title":"Overcoming skin barriers through advanced transdermal drug delivery approaches","volume":"351","author":"Phatale","year":"2022","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.138533_bb0640","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061152","article-title":"Beneath the skin: a review of current trends and future prospects of transdermal drug delivery systems","volume":"14","author":"Alkilani","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0645","first-page":"1","article-title":"Recent advancements and various potential applications of transdermal patches, International Journal of Polymeric Materials and Polymeric","author":"Abdul Razzaq","year":"2024","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0650","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2478\/acph-2019-0016","article-title":"Transdermal patches: design and current approaches to painless drug delivery","volume":"69","author":"Al Hanbali","year":"2019","journal-title":"Acta Pharma."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138533_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052401","article-title":"Recent advances of microneedles and their application in disease treatment","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.138533_bb0660","doi-asserted-by":"crossref","DOI":"10.3390\/polym14081608","article-title":"Microneedles in action: microneedling and microneedles-assisted transdermal delivery","volume":"14","author":"Lim","year":"2022","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0665","doi-asserted-by":"crossref","DOI":"10.1177\/20417314221085390","article-title":"Application of microneedle patches for drug delivery; doorstep to novel therapies","volume":"13","author":"Nazary Abrbekoh","year":"2022","journal-title":"J. Tissue Eng."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0670","article-title":"Current trends in polymer microneedle for transdermal drug delivery","volume":"587","author":"Al-Japairai","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0675","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.2042-7158.2011.01369.x","article-title":"Microneedles: an emerging transdermal drug delivery system","volume":"64","author":"Bariya","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121332","article-title":"Microneedle patch-assisted transdermal administration of recombinant hirudin for the treatment of thrombotic diseases","volume":"612","author":"Men","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0685","first-page":"284","article-title":"Design and fabrication of r-hirudin loaded dissolving microneedle patch for minimally invasive and long-term treatment of thromboembolic disease","volume":"17","author":"Wu","year":"2022","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0690","article-title":"Drug delivery systems","author":"Paolino","year":"2006","journal-title":"Encycl. Med. Devic. Instrument."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0695","first-page":"923","article-title":"The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection","volume":"9","author":"Jin","year":"2015","journal-title":"Patient Prefer Adher."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9798-5_1","article-title":"An overview of drug delivery systems","volume":"2059","author":"Jain","year":"2020","journal-title":"Drug Deliv. Syst."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.138533_bb0705","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073665","article-title":"Smart hydrogels for advanced drug delivery systems","volume":"23","author":"Bordbar-Khiabani","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.138533_bb0710","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0715","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jconrel.2006.11.024","article-title":"Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic F127 hydrogel for subcutaneous administration: in vitro and in vivo characterization","volume":"117","author":"Liu","year":"2007","journal-title":"J. Control. Release"},{"issue":"31","key":"10.1016\/j.ijbiomac.2024.138533_bb0720","doi-asserted-by":"crossref","first-page":"8895","DOI":"10.1016\/j.biomaterials.2014.06.051","article-title":"Poly(lactic-co-glycolic) acid microspheres encapsulated in Pluronic F-127 prolong hirudin delivery and improve functional recovery from a demyelination lesion","volume":"35","author":"Sellers","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2018.02.002","article-title":"Encapsulation, protection, and delivery of bioactive proteins and peptides using nanoparticle and microparticle systems: a review","volume":"253","author":"McClements","year":"2018","journal-title":"Adv. Colloid Interf. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.138533_bb0730","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000016102","article-title":"Intrathecal administration of thrombin inhibitor ameliorates cerebral vasospasm. Use of a drug delivery system releasing hirudin","volume":"10","author":"Kudo","year":"2000","journal-title":"Cerebrovasc. Dis."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.138533_bb0735","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/17458080.2015.1104925","article-title":"Enhanced antithrombotic effect of hirudin by bovine serum albumin nanoparticles","volume":"11","author":"Jing","year":"2016","journal-title":"J. Exp. Nanosci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.138533_bb0740","doi-asserted-by":"crossref","DOI":"10.3390\/polym14122510","article-title":"A review of polymeric micelles and their applications","volume":"14","author":"Perumal","year":"2022","journal-title":"Polymers (Basel)"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.138533_bb0745","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081636","article-title":"Progress in polymeric micelles for drug delivery applications","volume":"14","author":"Kotta","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0750","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030976","article-title":"Polymeric micellar systems-a special emphasis on \"smart\" drug delivery","volume":"15","author":"Negut","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0755","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1021\/mp900271r","article-title":"Nanoscaled polyion complex micelles for targeted delivery of recombinant hirudin to platelets based on cationic copolymer","volume":"7","author":"Wang","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120994","article-title":"Progress in nasal drug delivery systems","volume":"607","author":"Laffleur","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138533_bb0765","first-page":"328","article-title":"Factors affecting nasal drug delivery and design strategies for intranasal drug delivery","volume":"52","author":"Hu","year":"2023","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0770","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejmech.2019.01.007","article-title":"Composition design and medical application of liposomes","volume":"164","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138533_bb0775","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100639","article-title":"Liposomes and extracellular vesicles as drug delivery systems: a comparison of composition, pharmacokinetics, and functionalization","volume":"11","author":"van der Koog","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2022.102757","article-title":"Liposomes as biocompatible and smart delivery systems - the current state","volume":"309","author":"Dymek","year":"2022","journal-title":"Adv. Colloid Interf. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.138533_bb0785","first-page":"801","article-title":"Studies on preparation of recombinant hirudin-2 liposome and its pharmacokinetics by nasal delivery in rats","volume":"32","author":"Zhang","year":"2007","journal-title":"China J. Chin. Mater. Med."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.138533_bb0790","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1080\/10837450.2021.1950186","article-title":"Nanotechnologies for intranasal drug delivery: an update of literature","volume":"26","author":"Lombardo","year":"2021","journal-title":"Pharm. Dev. Technol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.138533_bb0795","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1745-7254.2005.00174.x","article-title":"Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo","volume":"26","author":"Zhang","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.138533_bb0800","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2174\/1389557514666140530093620","article-title":"Current concepts on cardiovascular stent devices","volume":"14","author":"Neamtu","year":"2014","journal-title":"Mini-Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101415","article-title":"Stent as a novel technology for coronary artery disease and their clinical manifestation","volume":"48","author":"Ullah","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.138533_bb0810","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.101.12.1453","article-title":"Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost","volume":"101","author":"Alt","year":"2000","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138533_bb0815","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.3390\/app14051939","article-title":"Preparation of hirudin-loaded chitosan\/polycaprolactone bowl-shaped particles and an application for a drug delivery system","volume":"14","author":"Li","year":"2024","journal-title":"Appl. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0820","first-page":"E3","article-title":"The stabilization and release of hirudin from liposomes or lipid-assemblies coated with hydrophobically modified dextran","volume":"1","author":"Mumper","year":"2000","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0825","first-page":"p29","article-title":"Preparation of micro and nanoparticulated systems based in degradable polyesters for encapsulation of hirudin and delivery","volume":"32","author":"Gonz\u00e1lez","year":"2023","journal-title":"Acta Microsc."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.138533_bb0830","doi-asserted-by":"crossref","first-page":"7649","DOI":"10.1021\/acsami.7b06108","article-title":"Polydopamine modified TiO(2) nanotube arrays for long-term controlled elution of bivalirudin and improved hemocompatibility","volume":"10","author":"Yang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0835","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1160\/TH16-05-0416","article-title":"A novel hirudin derivative inhibiting thrombin without bleeding for subcutaneous injection","volume":"117","author":"Zhao","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138533_bb0840","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12906-019-2531-7","article-title":"The effects of a hirudin\/liposome complex on a diabetic nephropathy rat model","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Complement. Altern. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.138533_bb0845","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.molpharmaceut.8b01325","article-title":"Novel strategy of gene delivery system based on dendrimer loaded recombinant hirudine plasmid for thrombus targeting therapy","volume":"16","author":"Chen","year":"2019","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.138533_bb0850","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.ultrasmedbio.2005.05.007","article-title":"Preparation, characterization and in vivo observation of phospholipid-based gas-filled microbubbles containing hirudin","volume":"31","author":"Zhao","year":"2005","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.ijbiomac.2024.138533_bb0855","doi-asserted-by":"crossref","first-page":"1301507","DOI":"10.3389\/fcvm.2023.1301507","article-title":"Bivalirudin-hydrogel coatings of polyvinyl chloride on extracorporeal membrane oxygenation for anticoagulation","volume":"10","author":"Gao","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.138533_bb0860","doi-asserted-by":"crossref","first-page":"18483","DOI":"10.1021\/acsnano.2c06666","article-title":"Platelet-covered nanocarriers for targeted delivery of hirudin to eliminate thrombotic complication in tumor therapy","volume":"16","author":"Zhang","year":"2022","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138533_bb0865","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2008.03.001","article-title":"Increase of the pharmacological and pharmacokinetic efficacy of negatively charged polypeptide recombinant hirudin in rats via parenteral route by association with cationic liposomes","volume":"128","author":"Meng","year":"2008","journal-title":"J. Control. Release"},{"issue":"51","key":"10.1016\/j.ijbiomac.2024.138533_bb0870","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202203184","article-title":"Biomimetic nanoplatelets to target delivery hirudin for site-specific photothermal\/photodynamic thrombolysis and preventing venous thrombus formation","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"issue":"41","key":"10.1016\/j.ijbiomac.2024.138533_bb0875","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc0382","article-title":"Self-regulated hirudin delivery for anticoagulant therapy","volume":"6","author":"Xu","year":"2020","journal-title":"Sci. Adv."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024093449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024093449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:48:20Z","timestamp":1782870500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024093449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":175,"alternative-id":["S0141813024093449"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138533","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel drug delivery systems for hirudin-based product development and clinical applications","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"138533"}}